Cancer stem cells, a small subpopulation of cells with stem cell-like characteristics found within most solid tumors, are widely reported to be responsible for the malignancy of aggressive cancer cells, and targeting these cells presents a sound therapeutic strategy for reducing the risk of tumor relapse. In the present study, we examined the effects of an extract of Saccharina japonica (ESJ) on glioblastoma stem cells (GSCs). Saccharina japonica is a member of the Phaeophyceae (brown algae) family, which displays biological activities, including antitumor effects. ESJ inhibited the sphere-forming ability of GSCs in vitro as evidenced by neurosphere formation and limiting dilution assays. Treatment with ESJ partially induced apoptosis, reduced cell invasiveness, and sensitized GSCs to ionizing radiation. In addition, ESJ inhibited the maintenance of stemness in GSCs by suppressing the expression of epidermal growth factor receptor (EGFR)/EGFR variant III (EGFRvIII) and Notch intracellular domain. Intriguingly, the observed ESJ-induced suppression also appeared to induce the proteasomal degradation of EGFR/EGFRvIII. Our results indicate that ESJ could be considered a potent therapeutic adjuvant that targets GSCs.
Get full access to this article
View all access options for this article.
References
1.
BleekerFE, MolenaarRJ, LeenstraS: Recent advances in the molecular understanding of glioblastoma. J Neuro-Oncol, 2012; 108:11–27.
2.
GallegoO: Nonsurgical treatment of recurrent glioblastoma. Curr Oncol, 2015; 22:E273–E281.
3.
FurnariFB, FentonT, BachooRM, et al.: Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev, 2007; 21:2683–2710.
4.
MuratA, MigliavaccaE, GorliaT, et al.: Stem cell-related “Self-Renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol, 2008; 26:3015–3024.
5.
IgnatovaTN, KukekovVG, LaywellED, SuslovON, VrionisFD, SteindlerDA: Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia, 2002; 39:193–206.
6.
LeeJ, KotliarovaS, KotliarovY, et al.: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 2006; 9:391–403.
7.
JordanCT, GuzmanML, NobleM: Mechanisms of disease—Cancer stem cells. N Engl J Med, 2006; 355:1253–1261.
8.
TakebeN, HarrisPJ, WarrenRQ, IvySP: Targeting cancer stem cells by inhibiting Wnt, notch, and Hedgehog pathways. Nat Rev Clin Oncol, 2011; 8:97–106.
9.
BaoSD, WuQL, McLendonRE, et al.: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 2006; 444:756–760.
10.
EramoA, Ricci-VitianiL, ZeunerA, et al.: Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ, 2006; 13:1238–1241.
11.
RichJN: Cancer stem cells in radiation resistance. Cancer Res, 2007; 67:8980–8984.
12.
ReyaT, MorrisonSJ, ClarkeMF, WeissmanIL: Stem cells, cancer, and cancer stem cells. Nature, 2001; 414:105–111.
13.
da RochaAB, LopesRM, SchwartsmannG: Natural products in anticancer therapy. Curr Opin Pharmacol, 2001; 1:364–369.
14.
NewmanDJ, CraggGM: Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod, 2012; 75:311–335.
15.
KimJ, LeeJS, JungJ, LimI, LeeJY, ParkMJ: Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variant III in glioma stem cells. Stem Cells Dev, 2015; 24:284–295.
16.
FedorovSN, ErmakovaSP, ZvyagintsevaTN, StonikVA: Anticancer and cancer preventive properties of marine polysaccharides: Some results and prospects. Mar Drugs, 2013; 11:4876–4901.
17.
CumashiA, UshakovaNA, PreobrazhenskayaME, et al.: A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology, 2007; 17:541–552.
18.
VishchukOS, ErmakovaSP, ZvyagintsevaTN: Sulfated polysaccharides from brown seaweeds Saccharina japonica and Undaria pinnatifida: Isolation, structural characteristics, and antitumor activity. Carbohydr Res, 2011; 346:2769–2776.
19.
GoH, HwangHJ, NamTJ: A glycoprotein from Laminaria japonica induces apoptosis in HT-29 colon cancer cells. Toxicol Vitro, 2010; 24:1546–1553.
20.
KimEJ, ParkSY, LeeJY, ParkJHY: Fucoidan present in brown algae induces apoptosis of human colon cancer cells. BMC Gastroenterol, 2010; 10:11.
21.
Yamasaki-MiyamotoY, YamasakiM, TachibanaH, YamadaK: Fucoidan induces apoptosis through activation of caspase-8 on human breast cancer MCF-7 cells. J Agric Food Chem, 2009; 57:8677–8682.
22.
SoedaA, ParkM, LeeD, et al.: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene, 2009; 28:3949–3959.
23.
KongBH, MoonJH, HuhYM, et al.: Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients. Stem Cells Int, 2014; 2014:838950.
24.
MaoP, JoshiK, LiJ, et al.: Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci U S A, 2013; 110:8644–8649.
25.
HatanpaaKJ, BurmaS, ZhaoDW, HabibAA: Epidermal growth factor receptor in glioma: Signal transduction, neuropathology, imaging, and radioresistance. Neoplasia, 2010; 12:675–684.
26.
HanahanD, WeinbergRA: Hallmarks of cancer: The next generation. Cell, 2011; 144:646–674.
27.
GieseA, BjerkvigR, BerensME, WestphalM: Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol, 2003; 21:1624–1636.
28.
Barrallo-GimenoA, NietoMA: The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development, 2005; 132:3151–3161.
29.
YamoutpourF, BodernpudiV, ParkSE, et al.: Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity. Mol Cancer Ther, 2008; 7:3586–3597.
30.
WangJL, WakemanTP, LathiaJD, et al.: Notch promotes radioresistance of glioma stem cells. Stem Cells, 2010; 28:17–28.
31.
LiYY, WichaMS, SchwartSJ, SunDX: Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J Nutr Biochem, 2011; 22:799–806.
32.
BalasubramanianS, AdhikaryG, EckertRL: The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis, 2010; 31:496–503.
33.
LiYY, ZhangT, KorkayaH, et al.: Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res, 2010; 16:2580–2590.
34.
KakaralaM, BrennerDE, KorkayaH, et al.: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat, 2010; 122:777–785.
35.
LiXX, DongY, WangW, et al.: Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma. Stem Cells Dev, 2013; 22:554–566.
36.
LeeJC, HouMF, HuangHW, et al.: Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties. Cancer Cell Int, 2013; 13:7.
37.
JoMJ, KimHR, KimGD: The anticancer effects of Saccharina japonica on 267B1/K-ras human prostate cancer cells. Int J Oncol, 2012; 41:1789–1797.
38.
PengZF, LiuM, FangZX, ChenL, WuJL, ZhangQQ: In vitro antiproliferative effect of a water-soluble Laminaria japonica polysaccharide on human melanoma cell line A375. Food Chem Toxicol, 2013; 58:56–60.
39.
ZhaiQZ, LiXL, YangYZ, YuL, YaoYQ: Antitumor activity of a polysaccharide fraction from Laminaria japonica on U14 cervical carcinoma-bearing mice. Tumor Biol, 2014; 35:117–122.
40.
ZhuQ, ChenJ, LiQ, WangT, LiH: Antitumor activity of polysaccharide from Laminaria japonica on mice bearing H22 liver cancer. Int J Biol Macromol, 2016; 92:156–158.
41.
ChungTW, ChoiHJ, LeeJY, et al.: Marine algal fucoxanthin inhibits the metastatic potential of cancer cells. Biochem Biophys Res Commun, 2013; 439:580–585.
42.
MellinghoffIK, WangMY, VivancoI, et al.: Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med, 2005; 353:2012–2024.
43.
HuangPH, MukasaA, BonaviaR, et al.: Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci U S A, 2007; 104:12867–12872.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
